In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis

Miltefosine was the first oral compound approved for visceral leishmaniasis chemotherapy, and its efficacy against Leishmania donovani has been well documented. Leishmania amazonensis is the second most prevalent species causing cutaneous leishmaniasis and the main etiological agent of diffuse cutan...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelho, Adriano C., Trinconi, Cristiana T., Costa, Carlos H. N., Uliana, Silvia R. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102453/
https://www.ncbi.nlm.nih.gov/pubmed/25033218
http://dx.doi.org/10.1371/journal.pntd.0002999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102453/
https://www.ncbi.nlm.nih.gov/pubmed/25033218
http://dx.doi.org/10.1371/journal.pntd.0002999

Ejemplares similares